Inventor · disambiguated record
Matthew Cox
Also filed as: COX MATTHEW · COX MATTHEW M
7 granted patents·14 pending applications·47 citations·filing 2005–2025
79Inventor score
Top patents by PatentIndex Score
21 records- 0192US7465726B2Substituted pyrrolo[2.3-B]pyridinesOSI PHARM INC·Filed 2005·Granted Dec 16, 2008·35 cites·14 claims
- 0287US7419995B2N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole libraryOSI PHARM INC·Filed 2005·Granted Sep 2, 2008·8 cites·16 claims
- 0386US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 0475US2023140047A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFORBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0563US2024066175A1Hydroxyl ion generator apparatuses for ceiling mount or walk throughTURNTEK LLC·Filed 2023·Application pending·0 cites
- 0658US8163901B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameDUNCTON MATTHEW·Filed 2009·Granted Apr 24, 2012·0 cites·5 claims
- 0753US2023041738A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0853US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0953US2009181940A1Imidazopyrazine Tyrosine Kinase InhibitorsOSI PHARM INC·Filed 2008·Application pending·0 cites
- 1053US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1153US2023348468A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1253US2020377578A1Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficileUCB BIOPHARMA SPRL·Filed 2020·Application pending·0 cites
- 1352US2025282786A1Tricyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1451US10752676B2Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficileHUMPHREYS DAVID PAUL·Filed 2012·Granted Aug 25, 2020·0 cites·43 claims
- 1549US8153651B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameCOX MATTHEW·Filed 2008·Granted Apr 10, 2012·0 cites·54 claims
- 1648US2011257208A1Compounds useful as faah modulators and uses thereofDUNCTON MATTHEW·Filed 2009·Application pending·0 cites
- 1746US2013045973A1Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameEVOTEC AG·Filed 2012·Application pending·0 cites
- 1845US2025282776A1Bicyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1944US2012088746A1Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameSHISHIDO YUJI·Filed 2007·Application pending·0 cites
- 2044US2010004222A1Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the SameRENOVIS INC·Filed 2007·Application pending·0 cites
- 2143US10766770B2Systems and methods of production of hydrogen containing compounds using products of fuel cellsGRANNUS LLC·Filed 2017·Granted Sep 8, 2020·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Cox files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →